India IVF, a tech-enabled fertility provider, has secured $1.25 million in pre-Series A funding from Tomorrow Capital. This marks the company’s first external investment since its founding in 2014 by Dr. Richika Sahay and Dr. Somendra Shukla, following a decade of profitable operations across five North Indian centers. The investment aims to support India IVF’s expansion across North India, addressing critical gaps…
Fellow Health, a provider of mail-in semen analysis services, has announced it has delivered over 100,000 patient test results since its product launch in 2020. The company reports its testing volume has increased by more than 50% year-to-date from 2023. The company’s mail-in semen analysis service aims to improve access to male fertility testing, addressing a market where 1 in 6 couples…
Parallel Fluidics, a company developing on-demand microfluidic manufacturing solutions with applications in IVF and other life science fields, has secured $7 million in seed funding. The round was led by J2 Ventures with participation from 8VC and Praxis. The company’s technology is already making waves in the fertility sector. Overture Life, a startup focused on simplifying IVF procedures, is utilizing Parallel Fluidics’…
Femasys has announced a strategic partnership with Boston IVF to offer FemaSeed, its FDA-cleared intratubal insemination product, across Boston IVF’s network of nearly 30 fertility centers in the U.S. The collaboration aims to expand access to alternative fertility treatment options before patients progress to more invasive procedures. “We are elated to welcome Boston IVF, a prominent conglomerate in the infertility space, to…
Extend Fertility has released the results of an 8-year comprehensive study on egg freezing success rates, providing new insights into the effectiveness of fertility preservation. The findings, presented at the American Society of Reproductive Medicine Conference in Denver, demonstrate significant success rates and changing trends in egg freezing demographics. The study, which followed 3,100 unique patients through 4,600 egg freezing cycles between…
In what could mark a significant shift in fertility treatment, Celmatix has announced the nomination of its first lead compound in its oral Follicle Stimulating Hormone receptor (FSHR) agonist drug development program. The breakthrough, announced during the American Society for Reproductive Medicine (ASRM) annual meeting in Denver, could potentially transform fertility treatments by replacing traditional hormone injections with oral medications. The development…
Legacy, a leading sperm testing and freezing company in the U.S., and Posterity Health, a virtual-first soltuion for male reproductive health, have announced a partnership to provide end-to-end male fertility and hormone health care. The collaboration creates a hybrid care model combining Legacy’s at-home testing capabilities with Posterity Health’s specialized treatment services. The program offers baseline semen analysis through Legacy to understand…
Astec, a global manufacturer of medical equipment for assisted reproduction, has acquired Life Whisperer, the AI fertility product developed by Presagen. Life Whisperer is a non-invasive and rapid embryo and egg (oocyte) assessment tool designed to improve pregnancy outcomes for IVF patients. Life Whisperer consists of three AI algorithms. The first, Life Whisperer Viability, assesses images of embryos to determine the likelihood…
